The Europe Neurovascular Devices Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
The burden of neurovascular disorders is being lessened because of technological advancements in healthcare. Various materials, including cobalt,nitinol,and platinum, can be used in neurovascular devices to provide specific properties for aneurysm repair and ischemic stroke prevention. The development of neurovascular devices and their rising popularity result from increased government investment in developing sophisticated healthcare infrastructure and enhanced participation in research and development initiatives.
By enabling improved treatments for various neurological disorders, the availability of technologically advanced neurovascular devices has significantly contributed to the market expansion. The main variables influencing the market for neurovascular devices include rising obesity rates, an aging population, and technical developments in interventional neurology.
Moreover, the aneurysm coiling & embolization devices areanticipated to witness significant demandwhich can be attributed to the expanding market supply of embolic coils for neurovascular treatment and the rising end-user interest in minimally invasive neurosurgery procedures. Neurological conditions such as strokes,brain aneurysms,and arteriovenous malformations (AVMs) are rising. Moreover, healthcare spending and R&D funding are rising, which are all driving the development of the neurovascular device market.
The Census results for 2021 show that the population of England &Wales has continued to age and that there are now more individuals than ever before across older age groups. Compared to 16.4% at the time of the previous census in 2011, almost 11 million persons, or 18.6% of the total population, were 65 or older. This includes 527,900 persons, or more than half a million, who were at least 90 years old. The region's market participants may have investment opportunities due to the increased risk of neurovascular illnesses brought on by the aging population.
The Germany market dominated the Europe Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $273.2 million by 2028. The UK market is anticipated to grow at a CAGR of 7.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 8.9% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
The burden of neurovascular disorders is being lessened because of technological advancements in healthcare. Various materials, including cobalt,nitinol,and platinum, can be used in neurovascular devices to provide specific properties for aneurysm repair and ischemic stroke prevention. The development of neurovascular devices and their rising popularity result from increased government investment in developing sophisticated healthcare infrastructure and enhanced participation in research and development initiatives.
By enabling improved treatments for various neurological disorders, the availability of technologically advanced neurovascular devices has significantly contributed to the market expansion. The main variables influencing the market for neurovascular devices include rising obesity rates, an aging population, and technical developments in interventional neurology.
Moreover, the aneurysm coiling & embolization devices areanticipated to witness significant demandwhich can be attributed to the expanding market supply of embolic coils for neurovascular treatment and the rising end-user interest in minimally invasive neurosurgery procedures. Neurological conditions such as strokes,brain aneurysms,and arteriovenous malformations (AVMs) are rising. Moreover, healthcare spending and R&D funding are rising, which are all driving the development of the neurovascular device market.
The Census results for 2021 show that the population of England &Wales has continued to age and that there are now more individuals than ever before across older age groups. Compared to 16.4% at the time of the previous census in 2011, almost 11 million persons, or 18.6% of the total population, were 65 or older. This includes 527,900 persons, or more than half a million, who were at least 90 years old. The region's market participants may have investment opportunities due to the increased risk of neurovascular illnesses brought on by the aging population.
The Germany market dominated the Europe Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $273.2 million by 2028. The UK market is anticipated to grow at a CAGR of 7.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 8.9% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
Scope of the Study
By End-user
- Hospital & Surgery Centers
- Ambulatory Care Centers
- Research laboratories & Academic Institutes
By Technology
- Embolization & Coiling
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Neurothrombectomy Devices
- Clot Retrievers
- Suction & Aspiration Devices
- Snares
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Support Devices
- Microcatheters
- Microguidewires
By Disease Pathology
- Cerebral Aneuryms
- Ischemic Strokes
- Cartoid Artery Stenosis
- Arteriovenous Malformation & Fistulas (AVM)
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Neurovascular Devices Market by End-user
Chapter 4. Europe Neurovascular Devices Market by Technology
Chapter 5. Europe Neurovascular Devices Market by Disease Pathology
Chapter 6. Europe Neurovascular Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Methodology
LOADING...
Related Reports
Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030
- Report
- 184 Pages
- Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report
- Report
- 179 Pages
- Global
From
Neurovascular Device Market
- Report
- 200 Pages
- Global
From
Neurovascular Devices Market Report by Product, End User, and Region 2024-2032
- Report
- 141 Pages
- Global
From
Neurovascular Devices Market Analysis & Forecast to 2024-2034
- Report
- 200 Pages
- Global
From
About the Market
The Neurovascular Device market is a subset of the Neurology Devices market, which focuses on the diagnosis and treatment of neurological disorders. Neurovascular Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to restore blood flow to the brain, reduce the risk of stroke, and improve patient outcomes. Neurovascular Devices include stents, embolic coils, flow diverters, and occlusion balloons. These devices are used in a variety Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
